Single center analysis of mycophenolate mofetil and Neoral/prednisone therapy for prophylaxis of rejection in African-American and Caucasian transplant recipients.
Weber
M
M
Department of Surgery, University of Pennsylvania Medical Center, Philadelphia 19104-6070, USA.
Ketchum
R J
RJ
Sellers
M
M
Aradhye
S
S
Deng
S
S
Grossman
R
R
Shaw
L
L
Naji
A
A
Barker
C
C
Brayman
K L
KL
D001379:Azathioprine / Q000627:therapeutic use; D044383:Black People; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008775:Methylprednisolone / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010414:Pennsylvania; D011241:Prednisone / Q000627:therapeutic use*; D044465:White People; D001741:Black or African American
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone